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Overview
1. Acute ischemic stroke (AIS): current management
2. Sedation vs General Anesthesia(GA) for EVT: Review of 
data from observational studies and retrospective analysis
3. Sedation Vs GA for EVT: Review of data from randomized 
controlled trials
4. Sedation vs GA for EVT: Ongoing trials
5. Volatile anesthetic vs total intravenous anesthesia(TIVA) 
for EVT
6. Sedation Vs GA: current concepts

EVT 6-24 hours: DAWN trial
n=206 ( 107 thrombectomy group, 99 control group)
(multicenter)
Outcome measure: 
1. Functional independence( mRS 0-2) was better with 
thrombectomy group compared to standard of care 
(49% vs 13%)
2. 90  day mortality did not differ between the two 
groups(19% vs 18%)
Ref: N Engl J Med 2018; 378:11-21
Thromberctomy in AIS  6-16 hours: 
Diffuse 3 trial
Multicenter US trial, 38 center, trial was terminated 
after recruiting 182 patients(90 EVT group, 90 medical 
therapy group)
Outcome measures
⚫Functional outcome better with thrombectomy 
compared to medical therapy (45% Vs 17%)
⚫Mortality rate at 90 days was lower with 
thrombectomy group compared to medical therapy 
group(14% vs 26%).
Ref: N Engl J Med 2018; 378:708-718
IV tPA really necessary?
AIS: EVT vs EVT with tPA(combination therapy)
⚫Multicenter RCT 41 tertiary academic centers(n=656)
⚫Outcome measures: Reperfusion: before thrombectomy (2.4% vs 
7.9%)
⚫Successful reperfusion after thrombectomy: 79.4% vs 84.5%
⚫Mortality 17.7% vs 18.8% at 90 days
⚫Conclusion: Endovascular thrombectomy alone is non-inferior to 
with regard to functional outcome at 90 days.
Ref:N Engl J Med 2020; 382:1981-1993
GA vs Sedation for EVT:Data from 
observational/retrospective analysis
Multiple observational studies/ retrospective analyses 
and their meta analyses reported :
Better functional neurological outcome with sedation 
compared to GA.
MR Clean: retrospective data





1. GA had worse outcome than LA (Odds ratio 0.75)
2. CS worse outcome than LA (Odds ratio 0.45)
3. CS had worse outcome than GA (Odds ratio 0.6)
Ref: NEJM journal watch Jan 7, 2020
Retrospective analysis of DIFFUSE 3 trial
n=92 (GA 26, 28% and sedation 66, 72%)
Results: Sedation compared to GA had
1. Lower NIHSS score at 24 hours
2. Better functional independence @ 90 days with  
mRS 0-2
Ref: Am J Neurol 2019;40-10011-5 
Limitation of observational studies
⚫Baseline neurological status was better in sedation 
group
⚫ Patients with posterior circulation stroke were not 
commonly included in sedation group
⚫Time to EVT is faster in sedation group
⚫BP during EVT was slower in GA group.




SIESTA 2016 Germany 150
AnStroke 2017 Sweden 90
Goliath 2018 Denmark 128
SIESTA trial(Sedation vs Intubation for 
Endovascular Stroke treatment)
Trial from Germany; single center RCT
n=150 (GA 73, sedation 77)
Anterior circulation AIS
Sedation: Conscious sedation




2. Am J Neuroradiol 2017; 38:1580-85
SIESTA
BP: 120-180 systolic
PaCo2: 35-45 mm Hg
SIESTA
Primary outcome measure: Early neurological 
recovery
Mean NIHSS Score GA Sedation
At admission 16.8 17.2
At 24 hours 13.6 13.6
Difference -3.2 -3.6
SIESTA: Secondary outcome measure at 3 months







Anesthesia During Stroke(AnStroke) 
trial 
n= 90 ( 45 sedation, 45 GA group ( conducted in 
Sweden)
GA vs sedation
GA= propofol and remifentanil for induction followed 
by sevoflurane and remifentanil maintenance
Sedation group: propofol and remifentanil
BP was maintained @ 140-180 mm Hg systolic with 
vasopressors.
Ref: Stroke 2017; 48:1601-7
Anstroke
Patient characteristics: Baseline neurological status 
was similar in both groups.
BP was maintained @ 140-180 mm Hg systolic with 
vasopressors.
PaCO2, blood glucose were comparable in both 
groups
Anstroke trial
Outcome measures: Functional outcome on modified 
rankin scale(mRS) at 90 days
19 out 45 patients in GA group(42.2%) and 18 out of 45 





Successful recanalization was similar in both 
groups(91.1% GA vs 88.9%)
In hospital mortality was similar in both groups(13.3%)
Ref: Stroke 2017;48:1601-1607
Goliath trial
GOLIATH: General Anesthesia Or Local Anesthesia in 
Intra-Arterial Therapy
n=128 ( 65 GA, 63 sedation)
Sedation protocol: fentanyl/propofol
GA protocol: Propofol/alfentanil/succinylcholine for 
induction
Propofol/remifentanil maintenance
Ref: JAMA Neurol 2018; 75:470-77
GOLIATH 
Primary outcome measure: Infarct size measured :
mRA 48-72 hours : No difference
Successful perfusion was better with GA croup 
compared to sedation group(76.9% Vs 60.3%)
Better functional outcome in GA group with mRS at 90 
days: Odds ratio: 1.91 (95% CI)
BP threholds in RCTs
BP thresholds in  three RCT for adverse  functional 
outcome(mRS @ 90 days)
MAP less than 70 mm Hg for 10 min or MAP greater 
than 90 mm Hg for more than 45 min had adverse 
outcome.
Ref: JAMA Neurol 2o20;77:622-31
Meta-analysis of  3 RCT’s
n=368 (Siesta, Anstroke, Goliath)
Results: 
1. Functional independence on (mRS 0-2)@ 90 days 
was better in GA group compared to sedation
(Odds ratio 1.87, 95% CI, 1.15-3.03)
1. No difference in mortality, anesthesia complications, 
pneumonia,  interventional complications and 
length of ICU stay.
Ref: J Am Heart Assoc 2019; 8e011754
Meta-analysis of  RCT’s
Conclusion: Moderate quality evidence suggests better 
outcome with GA.
Large RCTs are needed to confirm the benefit.
Ref: J Am Heart Assoc 2019; 8e011754
RCT from China: sedation Vs GA
n= 88 
TIVA was used in both groups
ETCO2 target was: 35-40 mm Hg
Conversion of sedation to GA: 9.52%
(SIESTA 14.3%, Goliath 15.6%)
No difference in functional outcome or mortality rate at 
90 days
Ref: Frontiers in Neurology; 
doi.org/10.3389/fneuro2020.00170
Ongoing trials : AMETIS trial 
AMETIS trial (Anesthesia Management in Endovascular 
Therapy for Acute Ischemic Stroke) (France)
(n=270) (Anterior circulation AIS)( multicenter)
Protocol: 
1.GA and sedation protocols are not standardized
2. Systolic BP should be maintained between 140-180 
systolic
3, End Tidal Co2 should be maintained at 30-35 mm Hg
Primary outcome measure: mRS 0-2 At 90 days
Ref: BMJ open 2019;9:e027561  NCT 03229148
Ongoing trialS: SEGA trial
SEdation Versus General Anesthesia for Endovascular 
Therapy in Acute Ischemic Stroke(SEGA)
Country: US
n=270
GA: protocol not standardized
Sedation: not standardized (fentanyl. midazolam, 
propofol intermittent bolus or low dose infusion, 
dexmedetomidine infusion with or without bolus at the 
discretion   of the anesthesiologist)
Ref: NCT 03263117
What  General Anesthesia 
technique?
⚫Total intravenous Anesthesia (TIVA)?
⚫Volatile anesthesia?
⚫Or combination of intravenous and volatile 
anesthetic agents?
Volatile agents Vs TIVA?
⚫A meta-analysis of  14 RCT’s 
⚫n= 1891
⚫ TIVA: Propofol/fentanyl and  Propofol/remifentanil 
⚫ Volatile anesthetic agents: Isoflurane/sevoflurane 
in air/oxygen mixture 
⚫ASA 1-3
⚫Patients had no or minimal midline shift on CT scan
Ref: Can J Anaesth 2014; 61:347-56
Volatile agents Vs TIVA
1. ICP= -5.2 mm/Hg less( 95% confidence interval -
6.81 to -3.6 mm HG)
2. CPP was +15.3 mm Hg ( 95% confidence interval 
12.2 to 20.46 mm Hg)
3. Limitations: Outcome measures were not studied 
in these trials of this meta-analysis.
Ref: Can J Anaesth 2014; 61:347-56
Volatile agents vs TIVA
TIVA alone  or with lower concentration of volatile 
anesthetic most commonly used popular technique in 
neurosurgical patients.
References;
1. Miller's anesthesia 9th edition 2020
2. UpToDate 2020
3. Pasternak JJ: Neuroanesthesiology Update. J Neurosurg 
Anesthesia 2019; 2; 178-98
TIVA Vs Volatile anesthesia?
⚫Propofol based TIVA maintains cerebral 
autoregulation curve and decreases the ICP.
⚫Volatile anesthetic agents suppress the cerebral 
autoregulation in a dose dependent manner.
Ref:
1. Armstead WM: Cerebral autoregulation and dysregulation. 
Anesthesiol Clin. 2016 34: 465–477
2. Miller’s Anesthesia 2020; 9th edition
Sharma: ASA 2019 meeting
Conclusion
GA vs sedation: What we should in 2020?
Choice of the technique depends on patients baseline 
neurological status. Choice of the technique depends on 
patients baseline neurological status as per 2019 ASA of 
AHA statement. 
Stroke 2019; 50:e344-e418
